Address	177-181, avenue Pierre Brossolette Montrouge Ile-de-France 92120 France
Employees	-
Website	http://www.dbv-technologies.com
Updated	07/08/2019
DBV Technologies SA is a clinical-stage biopharmaceutical company, which deals with conducting of research and development of epicutaneous immunotherapy products. It focuses on developing a novel technology platform called Viaskin, which is an electrostatic patch that offers a convenient, self-administered, non-invasive immunotherapy to patients. The company has designed two products candidates: Viaskin Peanut and Viaskin Milk.